
zzso zzso is the fourth leading cause of cancer mortality in the United States of zzso Progress in the treatment of this disease in the past several decades has been very zzso Several new agents with activity against pancreatic cancer have been zzso Of these, zzso is the most promising agent when used in combination with other zzso Pilot phase II studies combining zzso with zzso zzso zzso or zzso show improved outcomes in objective response rates and survival that need to be confirmed in larger zzso zzso Advancement in the understanding of the molecular biology of zzso in recent years has helped identify several molecular targets for future new drug development in pancreatic zzso Assessment of response to therapy of pancreatic cancer has been a difficult zzso zzso imaging with techniques such as zzso zzso zzso zzso may yield a more precise and timely objective evaluation of response to zzso 

